These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25533425)

  • 1. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.
    Pello AM; Cristóbal C; Tarín N; Huelmos A; Aceña Á; Carda R; González-Casaus ML; Alonso J; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Franco Peláez JA; Mahíllo-Fernández I; Farré J; López-Bescós L; Egido J; Tuñón J
    J Cardiol; 2015 Jul; 66(1):22-7. PubMed ID: 25533425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
    Martín-Reyes R; Franco-Peláez JA; Lorenzo Ó; González-Casaus ML; Pello AM; Aceña Á; Carda R; Martín-Ventura JL; Blanco-Colio L; Martín-Mariscal ML; Martínez-Milla J; Villa-Bellosta R; Piñero A; Navarro F; Egido J; Tuñón J
    PLoS One; 2016; 11(5):e0152816. PubMed ID: 27171378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.
    Aceña A; Franco-Peláez JA; Gutierrez-Landaluce C; Pello AM; Cristóbal C; Tarín N; Huelmos A; Carda R; Martín-Mariscal ML; Alonso J; González-Parra E; González-Casaus ML; Lorenzo Ó; López Bescos L; Egido J; Tuñón J
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):762-767. PubMed ID: 28803689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
    Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
    Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
    Tuñón J; Fernández-Fernández B; Carda R; Pello AM; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Hernández-González I; Mahíllo-Fernández I; López-Bescós L; Egido J
    Diabetes Metab Res Rev; 2016 Oct; 32(7):685-693. PubMed ID: 26888181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease].
    Higueras J; Martín-Ventura JL; Blanco-Colio L; Cristóbal C; Tarín N; Huelmos A; Alonso J; Pello A; Aceña Á; Carda R; Lorenzo Ó; Mahíllo-Fernández I; Asensio D; Almeida P; Rodríguez-Artalejo F; Farré J; López Bescós L; Egido J; Tuñón J
    Clin Investig Arterioscler; 2015; 27(2):57-63. PubMed ID: 25127747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
    Tuñón J; Higueras J; Tarín N; Cristóbal C; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Huelmos A; Alonso J; Aceña Á; Pello A; Carda R; Asensio D; Mahíllo-Fernández I; López Bescós L; Egido J; Farré J
    PLoS One; 2015; 10(6):e0126741. PubMed ID: 26046344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
    Tuñón J; González-Hernández I; Llanos-Jiménez L; Alonso-Martín J; Escudier-Villa JM; Tarín N; Cristóbal C; Sanz P; Pello AM; Aceña Á; Carda R; Orejas M; Tomás M; Beltrán P; Calero Rueda M; Marcos E; Serrano-Antolín JM; Gutiérrez-Landaluce C; Jiménez R; Cabezudo J; Curcio A; Peces-Barba G; González-Parra E; Muñoz-Siscart R; González-Casaus ML; Lorenzo A; Huelmos A; Goicolea J; Ibáñez B; Hernández G; Alonso-Pulpón LM; Farré J; Lorenzo Ó; Mahíllo-Fernández I; Egido J
    BMJ Open; 2016 Aug; 6(8):e011287. PubMed ID: 27496232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
    Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
    J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.
    Tuñón J; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Mahíllo-Fernández I; Pello AM; Carda R; Farré J; Rodríguez-Artalejo F; López-Bescós L; Egido J
    PLoS One; 2014; 9(4):e95402. PubMed ID: 24748388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-modality biomarkers in the early prediction of ischaemic heart disease in middle-aged men during a 21-year follow-up.
    Sakalaki M; Hansson PO; Rosengren A; Thunström E; Pivodic A; Fu M
    BMC Cardiovasc Disord; 2021 Feb; 21(1):65. PubMed ID: 33530933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
    Refsgaard Holm M; Christensen H; Rasmussen J; Johansen ML; Schou M; Faber J; Kistorp C
    ESC Heart Fail; 2019 Oct; 6(5):983-991. PubMed ID: 31429530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of liandou qingmai recipe on atherogenic indices of plasma and high-sensitivity C-reactive protein in patients with coronary heart disease].
    Zhu HJ; Lu S; Su W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):361-4. PubMed ID: 20669669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
    Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients.
    Gutiérrez-Landaluce C; Aceña Á; Pello A; Martínez-Milla J; González-Lorenzo Ó; Tarín N; Cristóbal C; Blanco-Colio LM; Martín-Ventura JL; Huelmos A; López-Castillo M; Alonso J; López Bescós L; Alonso-Pulpón L; González-Parra E; Egido J; Mahíllo-Fernández I; Lorenzo Ó; González-Casaus ML; Tuñón J
    ESC Heart Fail; 2021 Aug; 8(4):2713-2722. PubMed ID: 33932116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.